State of New Jersey Common Pension Fund D’s Monte Rosa Therapeutics GLUE Stock Holding History

State of New Jersey Common Pension Fund D’s Portfolio GLUE Stock Details GLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$174K	Buy	+10,553	New	+$202K	﹤0.01%	1536

Other funds holding GLUE

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

VPC

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

State of New Jersey Common Pension Fund D's GLUE Position: Q1 2026 in Review

State of New Jersey Common Pension Fund D opened a new position in Monte Rosa Therapeutics (GLUE) in Q1 2026: 10,553 shares worth $174K. The stake represents ﹤0.01% of the portfolio and ranks #1536 among its holdings.

190 funds tracked by Wall St. Rank hold GLUE as of Q1 2026.

State of New Jersey Common Pension Fund D held 10,553 shares of Monte Rosa Therapeutics worth $174K as of Q1 2026.
Monte Rosa Therapeutics was a new State of New Jersey Common Pension Fund D position in Q1 2026.
Monte Rosa Therapeutics made up ﹤0.01% of State of New Jersey Common Pension Fund D's portfolio in Q1 2026, its #1536 holding.
190 funds tracked by Wall St. Rank held Monte Rosa Therapeutics as of Q1 2026.

Based on State of New Jersey Common Pension Fund D's 13F filing for Q1 2026, filed 5 May 2026.